Scranton Richard 4
4 · Pacira BioSciences, Inc. · Filed Nov 12, 2019
Insider Transaction Report
Form 4
Scranton Richard
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2019-11-08$25.37/sh+4,750$120,508→ 35,509 total - Exercise/Conversion
Common Stock
2019-11-08$10.81/sh+14,698$158,885→ 30,759 total - Sale
Common Stock
2019-11-08$45.00/sh−19,448$875,160→ 16,061 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-08−14,698→ 0 totalExercise: $10.81Exp: 2022-06-05→ Common Stock (14,698 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-08−4,750→ 20,250 totalExercise: $25.37Exp: 2023-03-05→ Common Stock (4,750 underlying)
Footnotes (2)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock options are fully vested.